| Entry |
|
|---|
| Name |
Nafamostat (INN) |
|---|
| Formula |
C19H17N5O2
|
|---|
| Exact mass |
347.1382
|
|---|
| Mol weight |
347.3706
|
|---|
| Structure |
|
|---|
| Class |
|
|---|
| Remark |
| Product (DG01896): | D01670<JP> |
|
|---|
| Efficacy |
Anticoagulant, Antifibrinolytic, Serine protease inhibitor |
|---|
| Target |
serine proteases |
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01896 Nafamostat
D08240 Nafamostat
DG02016 Hemostatics
DG02012 Antifibrinolytic
DG01990 Serine protease inhibitor
DG01896 Nafamostat
D08240 Nafamostat
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01896 Nafamostat
DG02016 Hemostatics
DG02012 Antifibrinolytic
DG01990 Serine protease inhibitor
DG01896 Nafamostat
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 26
1 C8y C 29.2600 -16.6600
2 C8x C 30.4500 -15.9600
3 C8x C 31.6400 -16.6600
4 C8y C 31.6400 -18.0600
5 C8x C 30.4500 -18.7600
6 C8y C 29.2600 -18.0600
7 C7a C 24.3600 -16.6600
8 O7a O 25.6200 -15.9600
9 C8y C 26.8100 -16.6600
10 C8x C 28.0000 -15.9600
11 C8x C 28.0000 -18.7600
12 C8x C 26.8100 -18.0600
13 O6a O 24.3600 -18.0600
14 C2c C 32.9000 -18.7600
15 N2a N 34.0900 -18.0600
16 N1a N 32.9000 -20.1600
17 C8y C 23.1700 -15.9600
18 C8x C 20.7200 -15.9600
19 C8y C 20.7200 -14.5600
20 C8x C 21.9800 -13.8600
21 C8x C 23.1700 -14.5600
22 C8x C 21.9800 -16.6600
23 N1b N 19.5300 -13.8600
24 C2c C 18.3400 -14.5600
25 N2a N 17.0800 -13.8600
26 N1a N 18.3400 -15.9600
BOND 28
1 7 17 1
2 7 8 1
3 8 9 1
4 1 2 2
5 2 3 1
6 18 19 2
7 19 20 1
8 20 21 2
9 21 17 1
10 17 22 2
11 22 18 1
12 3 4 2
13 19 23 1
14 9 10 2
15 23 24 1
16 10 1 1
17 24 25 2
18 6 11 1
19 24 26 1
20 11 12 2
21 12 9 1
22 4 5 1
23 7 13 2
24 5 6 2
25 4 14 1
26 6 1 1
27 14 15 2
28 14 16 1
|
|---|
